Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

CS Diagnostics Corp (CSDX)

CS Diagnostics Corp (CSDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CS Group Announces the Valuation of MEDUSA Surface Disinfectant at USD 513 Million ACCESS Newswire - Tue Apr 22, 2025

CHEYENNE, WY AND NEUSS, GERMANY / ACCESS Newswire / April 22, 2025 / CS Group announced the completion of a comprehensive valuation for its proprietary smart surface disinfectant, MEDUSA. The valuation...

CSDX : 0.2490 (-0.40%)
CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS ACCESS Newswire - Tue Apr 15, 2025

CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading advisory and investment...

CSDX : 0.2490 (-0.40%)
OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval ACCESS Newswire - Wed Mar 12, 2025

CS DIAGNOSTICS CORP. ANNOUNCES THE APPOINTMENT OF FDA CONSULTANTS

CSDX : 0.2490 (-0.40%)

Barchart Exclusives

The Most Overlooked Dividend Kings to Buy in 2026 Barchart - 10 minutes ago
These overlooked Dividend Kings offer accelerating dividend growth, improving profitability, and long-term bullish momentum that income investors can rely on for consistent returns in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot